Digene has now merged with QIAGEN to create one, combined company that will be a market and technology leader in molecular diagnostics. The content of this Web site will soon be transferred to QIAGEN.com for corporate information and to theHPVtest.com for HPV/HPV testing information.

Members of the financial community should visit the Investor Relations section of QIAGEN.com for further information and contacts: http://www1.qiagen.com/about/InvestorRelation/